- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x RAP: RAPAMYCIN IMMUNOSUPPRESSANT DRUG(Non-covalent)
- 11 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 7 residues within 4Å:- Chain A: F.71, D.72, S.73, S.74, K.125
- Chain B: K.79, T.82
9 PLIP interactions:3 interactions with chain B, 6 interactions with chain A- Hydrogen bonds: B:T.82, A:D.72, A:S.73, A:S.74
- Water bridges: B:K.79, A:S.74, A:K.125
- Salt bridges: B:K.79, A:K.125
SO4.3: 3 residues within 4Å:- Chain A: K.62, K.64, K.70
3 PLIP interactions:3 interactions with chain A- Salt bridges: A:K.62, A:K.64, A:K.70
SO4.4: 4 residues within 4Å:- Chain A: S.17, P.18, T.19, K.64
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.19, A:T.19, A:T.19
- Salt bridges: A:K.64
SO4.5: 2 residues within 4Å:- Chain A: R.35, K.112
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:R.35, A:K.112
SO4.6: 4 residues within 4Å:- Chain A: K.56, Y.58, K.142
- Chain B: R.94
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:Y.58, B:R.94
- Salt bridges: A:K.56, A:K.142
SO4.7: 6 residues within 4Å:- Chain A: T.30, S.31, K.32, D.34, I.96, Y.115
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.31, A:K.32
SO4.8: 5 residues within 4Å:- Chain A: E.16, P.18, K.42, H.108, E.135
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:K.42, A:H.108
SO4.9: 2 residues within 4Å:- Chain B: T.48, L.49
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:L.49
SO4.10: 1 residues within 4Å:- Chain B: K.29
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:K.29
SO4.11: 1 residues within 4Å:- Chain B: R.94
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:R.94
SO4.12: 2 residues within 4Å:- Chain B: Q.56, R.60
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.56
- Salt bridges: B:R.60
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Marz, A.M. et al., Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin. Mol.Cell.Biol. (2013)
- Release Date
- 2013-02-06
- Peptides
- Peptidyl-prolyl cis-trans isomerase FKBP5: A
Serine/threonine-protein kinase mTOR: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x RAP: RAPAMYCIN IMMUNOSUPPRESSANT DRUG(Non-covalent)
- 11 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Marz, A.M. et al., Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin. Mol.Cell.Biol. (2013)
- Release Date
- 2013-02-06
- Peptides
- Peptidyl-prolyl cis-trans isomerase FKBP5: A
Serine/threonine-protein kinase mTOR: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B